Capsugel has entered a definitive agreement to acquire Bend Research as part of its Dosage Form Solutions (DFS) business unit. The acquisition enhances Capsugel’s DFS bioavailability expertise and provides access to a suite of technologies to address formulation challenges for oral drug delivery, as well as a full range of modified and targeted release solutions to develop new products for customers. The transaction is subject to customary closing conditions and is expected to be complete within...